The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabelled peptide designed to target with high affinity and specificity receptors overexpressed on tumours. PRRNT employing the radiotagged somatostatin receptor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaknun, John J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622744/
https://www.ncbi.nlm.nih.gov/pubmed/23389427
http://dx.doi.org/10.1007/s00259-012-2330-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622744/
https://www.ncbi.nlm.nih.gov/pubmed/23389427
http://dx.doi.org/10.1007/s00259-012-2330-6

Ejemplares similares